ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Senores Pharmaceuticals reported Q1 FY27 consolidated revenue of ₹180 crore, with EBITDA at ₹54 crore and PAT of ₹31 crore. Strong performance was driven by regulated markets.
Senores Pharmaceuticals reported Q4FY26 total income of ₹190 Crore, up 66% year-on-year. Strong performance was driven by regulated market growth and recent US-based acquisitions.